Sreeya S. Komaravolu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sreeya S. Komaravolu has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Aeen M. Asghar
Department of Urology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA
1 shared publication - Alice Drain
Departments of Urology and Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery UCLA Health Los Angeles California USA
1 shared publication - Angelo C. Lepore
Sidney Kimmel Medical College at Thomas Jefferson University
1 shared publication - Aziz M. Merchant
JFK University Medical Center and Hackensack Meridian School of Medicine
1 shared publication - Biswarup Ghosh
University of Kalyani
1 shared publication Brittany A. Charsar
Department of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107
1 shared publication
Latest Publications
- Open Access
- 1 January 2021
- Published by XMLink in Investigative and Clinical Urology
- Vol. 62 (1) , 65-71
Intermediate-term outcomes after robotic ureteral reconstruction for long-segment (≥4 centimeters) strictures in the proximal ureter: A multi-institutional experience
Lee M, et al. Investig Clin Urol. 2020 Aug;62:e6. https://doi.org/10.4111/icu.20200298
- 1 January 2021
- Published by XMLink in Investigative and Clinical Urology
- Vol. 62 (1) , 65-71
Open AccessIntermediate-term outcomes after robotic ureteral reconstruction for long-segment (≥4 centimeters) strictures in the proximal ureter: A multi-institutional experience
Lee M, et al. Investig Clin Urol. 2020 Aug;62:e6. https://doi.org/10.4111/icu.20200298
- Open Access
- 19 August 2019
- Published by Society for Neuroscience in eneuro
- Vol. 6 (5)
Long-Distance Axon Regeneration Promotes Recovery of Diaphragmatic Respiratory Function after Spinal Cord Injury
Compromise in inspiratory breathing following cervical spinal cord injury (SCI) is caused by damage to descending bulbospinal axons originating in the rostral ventral respiratory group (rVRG) and consequent denervation and silencing of phrenic motor neurons (PhMNs) that directly control diaphragm activation. In a rat model of high-cervical hemisection SCI, we performed systemic administration of an antagonist peptide directed against phosphatase and tensin homolog (PTEN), a central inhibitor of neuron-intrinsic axon growth potential. PTEN antagonist peptide (PAP4) robustly restored diaphragm function, as determined with electromyography (EMG) recordings in living SCI animals. PAP4 promoted substantial, long-distance regeneration of injured rVRG axons through the lesion and back toward PhMNs located throughout the C3–C5 spinal cord. These regrowing rVRG axons also formed putative excitatory synaptic connections with PhMNs, demonstrating reconnection of rVRG-PhMN-diaphragm circuitry. Lastly, re-lesion through the hemisection site completely ablated functional recovery induced by PAP4. Collectively, our findings demonstrate that axon regeneration in response to systemic PAP4 administration promoted recovery of diaphragmatic respiratory function after cervical SCI.
- 19 August 2019
- Published by Society for Neuroscience in eneuro
- Vol. 6 (5)
Open AccessLong-Distance Axon Regeneration Promotes Recovery of Diaphragmatic Respiratory Function after Spinal Cord Injury
Compromise in inspiratory breathing following cervical spinal cord injury (SCI) is caused by damage to descending bulbospinal axons originating in the rostral ventral respiratory group (rVRG) and consequent denervation and silencing of phrenic motor neurons (PhMNs) that directly control diaphragm activation. In a rat model of high-cervical hemisection SCI, we performed systemic administration of an antagonist peptide directed against phosphatase and tensin homolog (PTEN), a central inhibitor of neuron-intrinsic axon growth potential. PTEN antagonist peptide (PAP4) robustly restored diaphragm function, as determined with electromyography (EMG) recordings in living SCI animals. PAP4 promoted substantial, long-distance regeneration of injured rVRG axons through the lesion and back toward PhMNs located throughout the C3–C5 spinal cord. These regrowing rVRG axons also formed putative excitatory synaptic connections with PhMNs, demonstrating reconnection of rVRG-PhMN-diaphragm circuitry. Lastly, re-lesion through the hemisection site completely ablated functional recovery induced by PAP4. Collectively, our findings demonstrate that axon regeneration in response to systemic PAP4 administration promoted recovery of diaphragmatic respiratory function after cervical SCI.
- 1 August 2019
- Published by Elsevier in The American Journal of Surgery
- Vol. 218 (2) , 281-287
Colonoscopy utilization in rural areas by general surgeons: An analysis of the National Ambulatory Medical Care Survey
- 1 August 2019
- Published by Elsevier in The American Journal of Surgery
- Vol. 218 (2) , 281-287
Colonoscopy utilization in rural areas by general surgeons: An analysis of the National Ambulatory Medical Care Survey